|
|
FT China Healthcare and Life Sciences Summit 2010 will attract decision-makers from China and United Kingdom to share their knowledge in the operation of national healthcare systems. This event will provide an informative platform for the professionals to discuss on the exceptional opportunities being created across the entire value chain, ranging from provision of services, devices, provision of medical insurance to the development and research of new drug. FT China Healthcare and Life Sciences Summit 2010 will feature unparalleled level of insight from the foremost experts and leading organizations across the entire spectrum of healthcare and life sciences. It is a must attend event for those seeking invaluable knowledge & expertise in this field.
The FT China Healthcare and Life Sciences Summit 2010 will focus on numerous critical topics such as:
- Perspectives of financiers and investors on the growth potential and opportunities in China's expanding healthcare and life sciences markets
- China as a new epicenter for life sciences innovation and investment, new frontiers in vaccines, stem cell and cutting-edge biomedical research
- Critical assessments of China's healthcare reform programme
- Experiences shared from the UK's state healthcare system, and lessons that can be learned from successful and unsuccessful reforms in other countries
- Seizing the opportunities in China's life sciences, assessing the implications of healthcare reform for pricing, distribution, marketing and product strategies
- Gaining a foothold in the evolving retail, wholesaling and OTC markets in China
- Capitalizing on emerging opportunities in China's healthcare IT, medical devices, health insurance and medical services markets
Visitor Profile
The targeted visitors at FT China Healthcare and Life Sciences Summit 2010 would include:
- Researchers
- Engineers
- Scientists
- Industry Professionals
- Leading Pharmaceutical
- Key Regulatory Bodies
- Managers
- Practitioners
- Pharma Consultants
Organizer
FT Global conferences & Events
